In a 72-year-old patient who recently underwent coronary artery bypass grafting (two grafts) and bilateral thoracentesis for pleural effusions, currently receiving pregabalin (Lyrica) 75 mg three times daily, is it appropriate to reduce the dose to pregabalin 50 mg twice daily due to excessive sedation?

Dose Reduction of Pregabalin is Appropriate and Necessary

Yes, reducing pregabalin from 75 mg three times daily (225 mg/day) to 50 mg twice daily (100 mg/day) is appropriate and clinically indicated in this 72-year-old post-CABG patient experiencing excessive sedation.

Rationale for Dose Reduction

Dose-Dependent Sedation is Well-Established

Pregabalin produces dose-dependent dizziness and sedation, which can be particularly problematic in older adults 1. The FDA label explicitly states that these adverse effects "can be reduced by starting with lower dosages and titrating cautiously" 2. Your patient is experiencing the predictable consequence of an excessive dose in an elderly, post-surgical patient.

Current Dose Exceeds Recommended Starting Dose

According to FDA labeling, the recommended starting dose for pregabalin is 50 mg three times daily or 75 mg twice daily (150 mg/day) 2. Your patient is currently receiving 225 mg/day, which is 50% higher than the recommended starting dose. Guidelines emphasize that treatment should be "initiated at low dosages with gradual titration" 1.

Geriatric Considerations are Critical

The 2020 JAGS guidelines specifically recommend starting with pregabalin 25-50 mg/day in older adults and emphasizing that "the lowest starting doses are appropriate for patients" 3. The guideline explicitly states to use incremental dose escalation "at intervals long enough to allow monitoring of effects" and notes that "the effective dose in older adults may be lower" than standard ranges 3.

Additional Critical Considerations

Assess Renal Function Immediately

You must check creatinine clearance before making any dosing decision. Pregabalin is eliminated primarily by renal excretion, and dose adjustment is mandatory in renal impairment 2. Post-CABG patients frequently have compromised renal function, and your patient's recent bilateral pleural effusions suggest possible volume overload or cardiac dysfunction that could affect kidney function.

• If CLcr is 30-60 mL/min, the FDA recommends further dose reduction beyond what you're proposing 2
• Use the Cockcroft-Gault equation to estimate CLcr from serum creatinine 2

The Proposed Dose May Still Be Too High

Your proposed reduction to 50 mg twice daily (100 mg/day) may still be excessive for this elderly post-surgical patient. Consider:

• Starting at 25-50 mg/day total would be more consistent with geriatric guidelines 3
• You could initiate 25 mg twice daily (50 mg/day) and titrate up only if sedation resolves and pain control is inadequate
• The case report of a 76-year-old woman demonstrates that even 150 mg/day can cause significant adverse effects (balance disorder, asthenia, edema) in elderly patients 4

Monitor for Other Pregabalin-Related Issues

Beyond sedation, watch for:

• Peripheral edema - particularly concerning in a post-CABG patient with recent pleural effusions
• Dizziness and ataxia - fall risk is substantial in elderly post-surgical patients
• Cognitive impairment - "thinking abnormal" occurs in 3% of patients 2

Practical Implementation

Immediate action plan:

1. Check serum creatinine and calculate CLcr today
2. Reduce to 25 mg twice daily (50 mg/day) rather than your proposed 100 mg/day, especially if any renal impairment exists
3. Reassess sedation in 2-3 days - pregabalin has a relatively short half-life and effects should improve quickly
4. Titrate upward only if needed for pain control, increasing by 25-50 mg/day every 3-7 days as tolerated 3
5. Monitor for peripheral edema given recent pleural effusions

If Pain Control Becomes Inadequate

Recent cardiac surgery studies show that even low-dose pregabalin (75 mg twice daily for 48 hours postoperatively) significantly reduced opioid consumption without increasing adverse events 5. This suggests that lower doses can be effective. If 50 mg/day provides insufficient analgesia:

• Increase gradually to 75-100 mg/day in divided doses
• Consider adding acetaminophen (as demonstrated effective in the elderly case report) 4
• Reassess the indication - if this is for neuropathic pain, ensure the diagnosis is correct

Common Pitfall to Avoid

Do not continue the current dose while "monitoring." The excessive sedation in a 72-year-old post-CABG patient poses immediate risks including aspiration, falls, delayed mobilization, and respiratory depression. The evidence clearly supports that this adverse effect is dose-dependent and reversible with dose reduction 1, 3.